Continued from
Post #15
https://www.eanpages.org/2020/01/09/news-from-the-who/
January 9, 2020
Meeting of WHO with EFNA, EAN and EBC to discuss brain health Report
The WHO reps at this January 2020 meeting with neurology federations were: Dévora Kestel,
Tarun Dua, Neerja Chowdhary, Katrin Seeher, Alarcos Cieza.
According to this report, Dévora Kestel has replaced Dr Shekhar Saxena as Director of the WHO Department of Mental Health and Substance Abuse - the WHO Division that is also responsible for neurological disorders.
https://www.paho.org/hq/index.php?o...-de-sustancias-de-la-oms&Itemid=42050&lang=en
Dévora Kestel to direct WHO Department of Mental Health and Substance Abuse
Dévora Kestel, Chief of the Mental Health and Substance Use Unit at the Pan American Health Organization (PAHO/WHO), has recently been appointed as the new Director of Mental Health and Substance Abuse at the World Health Organization (WHO). She will be replacing Dr. Shekhar Saxena, who has served in this position since 2010 etc.
Dr Tarun Dua is a medical Officer at the WHO working on the
Program for Neurological Diseases and Neuroscience, Management of Mental and Brain Disorders in the Department of Mental Health and Substance Abuse.
She is the focal point for neurological disorders in the department.
She specialises in dementia and epilepsy and has co-authored research studies
here and
here, neurological reports, guidelines and other publications for the WHO.
https://www.alzheimer-europe.org/Co...es/2016-Copenhagen/Keynote-Speakers/Tarun-Dua
I am working as a Coordinator in the World’s Health Organization Headquarters in the Department of Mental Health and Substance Abuse. I am the focal point for neurological disorders in the department. I am leading the work on
dementia including the WHO/ADI report on dementia in 2012 “
Dementia: public health priority”, organization of First WHO Ministerial Conference on Global Action Against Dementia, March 2015 and the development of Global Dementia Observatory. I have been involved in the development of the mhGAP Guidelines on mental, neurological and substance use disorders (including dementia) and the latest edition of Disease Control Priorities in Developing Countries’ volume on mental, neurological and substance use disorders (including dementia).
1 Full text of ICD-11 proposal submitted by Dr Tarun Dua (apparently on behalf of TAG Neurology) on November 06, 2017; Processed on November 19, 2018:
https://dxrevisionwatch.files.wordp...1-proposal-dr-tarun-dua-november-06-201-1.pdf
In January 2018, Chapman & Dimmock submitted a robust response to the Dua proposal: Full text of our response:
http://bit.ly/2o8Gfbs
On November 19, 2018, the WHO rejected the Dua proposal in a decision supported by the WHO Medical and Scientific Advisory Committee (MSAC) and the Classification and Statistics Advisory Committee (CSAC) stating:
"In response to the many proposals on Chronic fatigue syndrome, the WHO Secretariat has conducted a vast amount of research.
Findings: The condition is characterized by chronic, profound, disabling, and unexplained fatigue and coinciding symptoms such as sleep problems or post-exertional malaise. There is no agreement on a reliable diagnostic symptom pattern. The etiology is still being discussed and there is no uniform treatment approach with reliable outcomes. The only constant is the lead symptom ‘fatigue’ that persists over time.
Decision: As a result of this study, the category ‘postviral fatigue’ that is the indexing target, will not be changed as currently there is no evidence to suggest a better place. The entity will retain its name and remain within the Nervous system chapter.
The Medical and Scientific Advisory Committee and the Classification and Statistics Advisory committee supported this decision." Team3 WHO 2018-Nov-19 - 07:10 UTC
-----------------------
Katrin Seeher is a Technical Officer at WHO and a psychologist and dementia specialist.
Dr Alarcos Cieza: Dr Cieza oversees the WHO's work on vision, hearing, rehabilitation and disability. Prior to joining the WHO in September 2014, she served as Chair and Professor of Medical Psychology at the Faculty of Social and Human Sciences at the University of Southampton, United Kingdom.
Edited to insert additional text.
